Treatment of emotional lability in ALS.
Meininger
Vincent
V
National Referral ALS Center, Salpétrière, Paris, France. vincent.meininger@psl.aphp.fr <vincent.meininger@psl.aphp.fr>
D000342:Affective Symptoms / Q000188:drug therapy* / Q000209:etiology; D000690:Amyotrophic Lateral Sclerosis / Q000150:complications*; D000818:Animals; D003915:Dextromethorphan / Q000627:therapeutic use*; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D018691:Excitatory Amino Acid Antagonists / Q000627:therapeutic use*; D006801:Humans; D011802:Quinidine / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic
D004791:Enzyme Inhibitors; D018691:Excitatory Amino Acid Antagonists; D003915:Dextromethorphan; D011802:Quinidine